Promising Remote Patient Monitoring solution, Polso™, Achieves 1st FDA Clearance

December 6th, 2022 Yokneam, Israel, December 6th, 2022 – ChroniSense Medical Ltd. took a step towards its vision of transforming chronic care management with Polso™, the company’s Remote Patient Monitoring (RPM) solution, achieving 510(k) clearance from the U.S. Food and Drug Administration (FDA).  Initial indications include monitoring of blood...